KOPRAN
|
The Current P/E Ratio of KOPRAN is 18.14.
Share Price | ₹178.4 | May 09,2025 |
Market Cap | ₹861.4 Cr | |
Earnings-TTM | ₹47.5 Cr | TTM-Consolidated Results |
Price/Earnings | 18.14x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of KOPRAN
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹861.4 Cr] as on May 09,2025
(/) Earnings [ ₹47.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 18.14x ]
Thus, for KOPRAN , the investors are currently willing to pay 18.14 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of KOPRAN !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of KOPRAN over the last five years.
Historical PE (Price/Earnings) ratio chart of KOPRAN
PE Ratio Performance Analysis for KOPRAN
- KOPRAN 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 15.77x.
- KOPRAN 's operated at median p/e ratio of 19.55x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KOPRAN 's p/e ratio peaked in Mar2024 at 24.45x.
- KOPRAN 's p/e ratio hit its five-year low in Mar2020 of 5.22x.
How does KOPRAN 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
KOPRAN | 47.49 | 18.14 | 861.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 36.45 | 418,648.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 77.07 | 159,310.0 |
CIPLA LTD | 5,000.43 | 23.88 | 119,410.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 57.03 | 106,189.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 16.92 | 96,496.4 |
MANKIND PHARMA LTD | 2,050.73 | 48.55 | 99,569.6 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.24 | 88,337.3 |
LUPIN LTD | 2,892.10 | 32.17 | 93,051.6 |
AUROBINDO PHARMA LTD | 3,500.25 | 19.31 | 67,585.0 |
ABBOTT INDIA LTD | 1,334.46 | 48.01 | 64,061.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs KOPRAN 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 16.92x |
Max industry PE | 77.07x |
Median industry PE | 32.17x |
Average industry PE | 36.07x |
You may also like the below Video Courses